SEARCH RESULTS
330959 RESULTS
Ian D'Souza
Seattle, United States
PAPER Qiu J, Li W, Feng SH, Wang M, He ZY
Ginsenoside Rh2 promotes nonamyloidgenic cleavage of amyloid precursor protein via a cholesterol-dependent pathway.
Genet Mol Res. 2014 May 9;13(2):3586-98. PubMed: 24854439PAPER Zeidán-Chuliá F, de Oliveira BH, Salmina AB, Casanova MF, Gelain DP, Noda M, Verkhratsky A, Moreira JC
Altered expression of Alzheimer's disease-related genes in the cerebellum of autistic patients: a model for disrupted brain connectome and therapy.
Cell Death Dis. 2014 May 22;5:e1250. PubMed: 24853428PAPER Beyer N, Coulson DT, Quinn JG, Brockbank S, Hellemans J, Irvine GB, Ravid R, Johnston JA
mRNA levels of BACE1 and its interacting proteins, RTN3 and PPIL2, correlate in human post mortem brain tissue.
Neuroscience. 2014 Aug 22;274:44-52. Epub 2014 May 20 PubMed: 24853053PAPER Shioda N, Yabuki Y, Kobayashi Y, Onozato M, Owada Y, Fukunaga K
FABP3 protein promotes α-synuclein oligomerization associated with 1-methyl-1,2,3,6-tetrahydropiridine-induced neurotoxicity.
J Biol Chem. 2014 Jul 4;289(27):18957-65. Epub 2014 May 22 PubMed: 24855640PAPER Thakur P, Nehru B
Modulatory effects of sodium salicylate on the factors affecting protein aggregation during rotenone induced Parkinson's disease pathology.
Neurochem Int. 2014 Sep;75:1-10. Epub 2014 May 19 PubMed: 24852355PAPER Follmer C
Monoamine oxidase and α-synuclein as targets in Parkinson's disease therapy.
Expert Rev Neurother. 2014 Jun;14(6):703-16. PubMed: 24852232PAPER Lindström V, Fagerqvist T, Nordström E, Eriksson F, Lord A, Tucker S, Andersson J, Johannesson M, Schell H, Kahle PJ, Möller C, Gellerfors P, Bergström J, Lannfelt L, Ingelsson M
Immunotherapy targeting α-synuclein protofibrils reduced pathology in (Thy-1)-h[A30P] α-synuclein mice.
Neurobiol Dis. 2014 Sep;69:134-43. Epub 2014 May 20 PubMed: 24851801PAPER Waldron EJ, Barrash J, Swenson A, Tranel D
Personality disturbances in amyotrophic lateral sclerosis: a case study demonstrating changes in personality without cognitive deficits.
J Int Neuropsychol Soc. 2014 Aug;20(7):764-71. Epub 2014 May 23 PubMed: 24854881PAPER Cleary JD, Ranum LP
Repeat associated non-ATG (RAN) translation: new starts in microsatellite expansion disorders.
Curr Opin Genet Dev. 2014 May 19;26C:6-15. PubMed: 24852074PAPER Wennström M, Nielsen HM, Orhan F, Londos E, Minthon L, Erhardt S
Kynurenic Acid levels in cerebrospinal fluid from patients with Alzheimer's disease or dementia with lewy bodies.
Int J Tryptophan Res. 2014;7:1-7. Epub 2014 Apr 28 PubMed: 24855376PAPER Umegaki H
Impaired glycemia and Alzheimer's disease.
Neurobiol Aging. 2014 Oct;35(10):e21. Epub 2014 Apr 26 PubMed: 24854798PAPER Knowles TP, Vendruscolo M, Dobson CM
The amyloid state and its association with protein misfolding diseases.
Nat Rev Mol Cell Biol. 2014 Jun;15(6):384-96. PubMed: 24854788PAPER Xuan AG, Pan XB, Wei P, Ji WD, Zhang WJ, Liu JH, Hong LP, Chen WL, Long DH
Valproic Acid Alleviates Memory Deficits and Attenuates Amyloid-β Deposition in Transgenic Mouse Model of Alzheimer's Disease.
Mol Neurobiol. 2014 May 23; PubMed: 24854198Current Filters
No filters selected